Head-to-head · Value Score
bmiMD vs Curex
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Curex a 81. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameCurex
#55 · Grade B · Good Value
Est. first month
From $199/mo (compounded oral)
Save ~85% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 81 — an est. $99/mo first month, with no teaser step-up baked in. Curex isn't out of it: Shoppers who want affordable compounded GLP-1 with strong corporate transparency and pharmacy testing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Curex |
|---|---|---|
| Value Score | 89 (A) | 81 (B) |
| Est. first month | $99/mo | From $199/mo (compounded oral) |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | From $199/mo (compounded oral) |
| Tirzepatide | $139/mo | From $199/mo (compounded oral) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 45 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Curex
Curex (Curex, Inc.) offers compounded semaglutide ($149/mo) and tirzepatide ($199/mo) in injectable and oral dissolving tablet formats.
Why it's a deal
- LegitScript certified
- Named entity (Curex, Inc.) with two offices — Miami FL and NYC
- No membership fee ever
- Injectable and oral dissolving tablet formats
- Third-party lab testing via FDA/DEA certified labs
The fine print
- Not available in AK, AR, CT, HI, MA, NM, MO
- Compounded only — explicitly states 'We don't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro'
- Primary business is allergy immunotherapy — GLP-1 is a newer vertical
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Curex.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.